Friedl-Naderer Johanna bought DYN
February 12, 2026 · Form 4 insider transaction
Friedl-Naderer Johanna bought 60,000 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderFriedl-Naderer Johanna
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after154,729
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares of Common Stock issuable under 60,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026.; Includes 132,152 unvested RSUs.